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and specifi city of the screening test process in diagnosing uterine cervical cancer. Cervical cancer develops by multilevel cancer steps. It is well known that the high risk human papilloma virus (HPV) is closely related to the onset of cervical cancer. Persistent HPV infection can cause cervical dysplasia and contribute to cancer development by affecting the restoration & apoptosis of damaged cells. That is, HPV E6 destroys p53 [5] and HPV E7 inactivates products of rentinoblastoma (pRB), and this can increase the expression of p16
INK4A [6] . p16 INK4A is involved in the G1 cell cycle which is an important stage for the repair and extinction of damaged cells. Accordingly, it is suggested that expression of p16 INK4A can help in screening tumor cells. Galectin-3 is one of the genetic families widely distributed in carbohydrate binding hormones, expressed variably in tumor cells and involved in cellular growth, differentiation, inflammation, apoptosis and metastasis [7] [8] [9] [10] [11] [12] . It has not yet been shown defi nitively how galectin-3 affects tumor progression but it is clear that expression of galectin-3 differs according to the type of tissue from which a tumor arises [13, 14] . The author compared the expression of p16 INK4A and galectin-3 in normal uterine cervix, precancerous lesions including low grade squamous intraepithelial lesions (LSILs), high grade squamous intraepithelial lesions (HSILs) and invasive cancer to determine if there is some difference between these lesions. 
Materials and Methods

Tissue samples
Interpretation of staining results
We examined all the slides with an optical microscope at ×100 fi eld and also examined the checked number of cells, which presented positive at ×400 fi eld. Two independent observers evaluated the staining of the slides and we analyzed the proportion and intensity of the staining responses in the cell and nucleus. In p16
INK4A
, a proportion of stained cells < 1% means 0, 1-4% means 1 +, 5-25% means 2 +, 25-75% means 3 +, and > 75% means 4 +. In galectin-3, proportion of stained cells < 5% means 0, 5-25% means 1 +, 25-50% means 2 +, 51-75% means 3 +, and > 75% means 4.
Statistical analysis
A one-way analysis of variance (ANOVA) was used to evaluate the differences in the expression of p16
INK4A and galectin-3 between normal and abnormal tissue, including LSIL, HSIL, and invasive cervical cancer. Analysis was done by SPSS 15.0. P-value < 0.05 was statistically signifi cant.
Results
Expression of p16 INK4A protein
The proportion of p16 INK4A expression was negative in 95% cases of normal epithelium, and the mean value was 0.1. In LSILs, the proportion was 1 + or 2 + in 76.5% and the mean value was 1.35.
There was no negative response, 1+ or 2+ in HSILs. 3 + comprised 57.7% and 4 + was 42.3% of cases of HSILs, and the average value was 3.42. In invasive cancer, = 3 + was 100%, 3 + was 20.8%, 4 + was 79.2%, and the average value was 3.79 ( Fig. 1 ). There was a statistical signifi cance between the proportion of p16 INK4A protein expression and the grade of uterine cervical lesion (P < 0.05) ( Table 1) . Sun-suk Kim, et al. Is the expression of p16 INK4A and galectin-3 correlated with disease progression of cervical neoplasia? 
Expression of galectin-3 protein
The proportion of galectin-3 expression was negative, 1 +, or 2 + in 95% cases of normal epithelium, and the average value was 1.70. In LSILs, it was 2 + or 3 + in 94.1% of cases, and the average value was 2.17. It was ≥ 3 + in 80.8% of HSILs, and the average value was 3.11. Although the proportion of galectin-3 was ≥ 3 + in 75% of invasive cancers, the average value was 3.08 ( Fig. 2) . Therefore no major difference between HSILs and invasive cancers existed in regard to the proportion of galectin-3 expression (P = 1.00) ( Table 2) . However there was a statistical signifi cance between the proportion of galectin-3 expression and the grade of cervical lesions like p16 INK4A (P < 0.05) ( Table 2 , Fig. 3 ).
Discussion
Cervical cancer arises from carcinoma in situ, which originates from precancerous lesions in normal cervical epithelium, or cervical dysplasia. HPV infection is recognized as the most prevalent cause of cervical cancer. HPV E6 destroys p53 [5] and HPV E7 inactivates pRB, potentially increasing the expression of p16 INK4A with persistent HPV infection [6] . p16 INK4A gene, a cyclin-dependent kinase (cdk) suppressor factor, regulates the activity of cdk4 and cdk6, and is inactivated by genetic defect or hypermethylation in many types of cancers [15, 16] . Therefore, further analysis is needed to make clear the relevance of HPV infection to p16 INK4A expression.
Galectin-3, 31-kDa, a kind of carbohydrate binding protein, has a chemical affi nity to β-galactosides, and has the homology of genetic arrangement in carbohydrate binding lesion [7] . Galectin-3 had been known as Carbohydrate binding protein-35 (CBP-35), Mac-2, L-29, L-34, or L-31. It consists of aminoterminal including repetitive genetic arrangement, which is abundant in leucine, tyrosine & proline, and globular structure including carbohydrate binding lesion [7] [8] [9] [10] [11] [12] [13] [14] . Galectin-3 responds to special kind of ligands, and is present in a number of biological steps such as cellular growth, differentiation, inflammation, modification, me- tastasis and adhesion. Galectin-3 is secreted by tumor cells and macrophages, induces chemotaxis by affecting vascular intraepithelium, and accelerates motility in early stage of tumor formation [11] . The importance of galectin-3 expression in many types of human tumors has been studied. Galectin-3 expression has been found to be higher in pancreatic, gastric, thyroid, head & neck, renal, colon, rectal, liver cancer and leiomyosarcoma than in normal cells. On the other hand, there are conflicting results in regard to other types of tumors. Galectin-3 expression, for example, is lower in breast, ovarian and endometrial cancer than normal cells. In metastatic cancer, the frequency of galectin-3 expression is higher than in primary cancer [24] . The only report regarding the relationship between grades of cervical lesions and galectin-3 expression is by Lee et al. [25] which concluded that galectin-3 expression decreases as the cervical lesion progresses [25] . But our conclusion is contrary to Lee's fi ndings. In our study, more than 50% expression was only found at 5% in normal epithelium, 23.5% in LSILs, and 70-80% in HSILs & invasive cancers. Additionally, the intensity of galectin-3 expression increased as the cervical lesion progressed to invasive cancer. Thus, we could use galectin-3 immunohistochemical staining as a tool in diagnosing and supposing uterine cervical lesions. But it is thought that larger scale research is needed, in order to consider the rise and fall in galectin-3 expression as cervical lesions progress. 
